Resultados de la búsqueda 1011-1020 of 7466 for sex therapy
... therapy to improve the treatment of future patients. Circulating Tumor Nucleic Acids To Monitor Treatment Response In Metastatic Melanoma Patients.
The purpose of this study is to evaluate the safety [including dose-limiting toxicities (DLTs)] of the combination therapy of TILT-123 and pembrolizumab in ...
... treatment response to targeted therapy and immunotherapy for patients who have stage IV metastatic melanoma. A Study to Collect Medical and Personal ...
Ascorbic Acid And Chemotherapy For The Treatment Of Relapsed Or Refractory Lymphoma, CCUS, And Chronic Myelomonocytic Leukemia. Rochester, Minn., Mankato, Minn.
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
This clinical trial evaluates the impact of preexisting and therapy-emergent germline and somatic variants on cytopenia in patients with multiple myeloma or ...
The purpose of this study is to compare standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed acute myeloid ...
Actinium Therapy For Late-stage Aggressive Sarcomas. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The goal of this clinical trial is to ...
... treatment. 3D Ultrasound Imaging For Breast Cancer Diagnosis. Rochester, Minn ... Actinium Therapy For Late-stage Aggressive Sarcomas. Rochester, Minn ...
The genetic analysis will be measured against clinical outcomes and treatment response (response to non-coated and drug-coated technologies and different ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?